Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001213900-25-014240·Jacobs Ian Seth
Schedule 13G ownership disclosure
Lomond Therapeutics Holdings, Inc.
Common Stock, par value $0.0001 per share · CUSIP: 54173L101
Event date: 2024-12-31
- Filing-level shares
- 175,000.00
- Percent of class
- 0.59%
- Ian Jacobs
Shares: 175,000.00 · Class: 0.59%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-014240
- Form type
- SCHEDULE 13G/A
- Filer
- Jacobs Ian Seth
- CIK
- CIK 1707297
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership